Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01610752 · ClinicalTrials.gov registry record · NA

Personalized Management of Body Weight During Pregnancy

A NA study of Weight Gain During Pregnancy, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
54
Enrollment target
2
Study locations

NCT01610752: Completed NA study of Weight Gain During Pregnancy, sponsored by Pennington Biomedical Research Center.

NCT01610752 is a NA study of Weight Gain During Pregnancy that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01610752, a NA study of Weight Gain During Pregnancy, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
54 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine how to help manage weight gain during pregnancy. This study is part of the National Consortium 'LIFE-Moms: Lifestyle interventions in expectant moms'. LIFE-Moms is 7 studies funded to test different lifestyle interventions in overweight and obese pregnant women.

Primary Outcome

Count of pregnant women who gain more weight during pregnancy than is recommended by the Institute of Medicine Gestational Weight Gain guidelines

Interventions

  • BEHAVIORAL SmartMoms

Study Locations (2)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge
  • Woman's Hospital - Baton Rouge

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2012-12
Est. Completion 2015-10
Phase NA

What the finished NCT01610752 record still lists

NCT01610752 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Weight Gain During Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which SmartMoms is the first listed.

NCT01610752 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT01610752 about?

NCT01610752 is a clinical study titled "Personalized Management of Body Weight During Pregnancy". The purpose of this study is to determine how to help manage weight gain during pregnancy. This study is part of the National Consortium 'LIFE-Moms: Lifestyle interventions in expectant moms'. LIFE-Moms is 7 studies funded to test different lifestyle interventions in overweight and obese pregnant wo...

What is the current status of trial NCT01610752?

This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2012-12. Estimated completion is 2015-10.

What conditions does trial NCT01610752 study?

This clinical trial studies the following conditions: Weight Gain During Pregnancy.

What interventions are being tested in trial NCT01610752?

The interventions under investigation include: SmartMoms (BEHAVIORAL).

Who is sponsoring clinical trial NCT01610752?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01610752 being conducted?

This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT01610752's enrollment target sits among peer trials

54 1268th of 2000 higher than 730 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269853 · 54 participants · Phase 1

    Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

  • NCT02390752 · 54 participants · Phase 1

    Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

  • NCT02991248 · 54 participants · NA

    Improve Dynamic Lateral Balance of Humans With SCI

  • NCT02993900 · 54 participants · NA

    Image-Guided Gynecologic Brachytherapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01610752, the US trial registry maintained by the National Library of Medicine. NCT01610752 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.